Evidence map›Paper›PMID 35869132›Full record

ArticleScientific reports2022

A comprehensive analysis of meloxicam particles produced by nanosecond laser ablation as a wet milling technique.

Eszter Nagy, Zsolt Homik, Tamás Smausz, Judit Kopniczky, Máté Náfrádi, Tünde Alapi, David Kokai, Katalin Burián, Piroska Szabó-Révész, Rita Ambrus and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Eszter NagyDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, Szeged, 6720, Hungary. nagyeszter.physx@gmail.com.
Zsolt HomikDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, Szeged, 6720, Hungary.
Tamás SmauszDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, Szeged, 6720, Hungary.
Judit KopniczkyDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, Szeged, 6720, Hungary.
Máté NáfrádiDepartment of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, Szeged, 6720, Hungary.
Tünde AlapiDepartment of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, Szeged, 6720, Hungary.
David KokaiDepartment of Medical Microbiology, Albert Szent-Györgyi Medical School, University of Szeged, Dóm tér 10, Szeged, 6720, Hungary.
Katalin BuriánDepartment of Medical Microbiology, Albert Szent-Györgyi Medical School, University of Szeged, Dóm tér 10, Szeged, 6720, Hungary.
Piroska Szabó-RévészInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös utca 6, Szeged, 6720, Hungary.
Rita AmbrusInstitute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös utca 6, Szeged, 6720, Hungary.
Béla HoppDepartment of Optics and Quantum Electronics, University of Szeged, Dóm tér 9, Szeged, 6720, Hungary.
University of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the number of water insoluble and poorly soluble drug compounds has increased significantly. Therefore, growing interest has been witnessed in different particle size reduction techniques to improve the dissolution rates, transport characteristics and bioavailability of drugs. Laser ablation has proven to be an alternative method to the production of nano- and micrometre-sized drug particles without considerable chemical damage. We present the nanosecond laser ablation of drug pastilles in distilled water, targeting meloxicam, a poorly water soluble nonsteroidal anti-inflammatory drug, at different laser wavelengths (248 nm, 532 nm and 1064 nm). Besides chemical characterization, crystallinity, morphology and particle size studies, the mechanism of the particle generation process was examined. The applicability of ablated particles in drug formulation was investigated by solubility, cytotoxicity and anti-inflammatory effect measurements. We showed that laser ablation is a clean, efficient and chemically non-damaging method to reduce the size of meloxicam particles to the sub-micrometre-few micrometre size range, which is optimal for pulmonary drug delivery. Complemented by the excellent solubility (four to nine times higher) and anti-inflammatory (four to five times better) properties of the particles compared to the initial drug, laser ablation is predicted to have wider applications in the development of drug formulations.

Indexed as

Laser TherapyNanoparticlesDrug CompoundingMeloxicamParticle SizeSolubilityWaterMeloxicamWater

Identifiers

PMID35869132
PMCPMC9307616
OpenAlexW4286560029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.